Menopause Treatments
Find Menopause Treatments
Medications for Menopause
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Menopause.
Found 10 Approved Drugs for Menopause
MedroxyPROGESTERone Acetate
Brand Names
Prempro, Depo-SubQ Provera, Premphase, Provera, Depo-Provera, MedroxyPROGESTERone
MedroxyPROGESTERone Acetate
Brand Names
Prempro, Depo-SubQ Provera, Premphase, Provera, Depo-Provera, MedroxyPROGESTERone
Form: Injection, Tablet, Kit
Method of administration: Subcutaneous, Oral, Intramuscular
FDA approval date: June 03, 1959
Classification: Progestin
Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens.
Norethindrone Acetate
Brand Names
24FE, Nylia, Sharobel, Hailey 24, Tarina, Vyfemla, Deblitane, Wymzya, Aurovela, Lyleq, Mibelas 24, Etyqa, Luizza, Gallifrey, Junel 21, Microgestin 24, Affodel, Abigale, Femlyv, Philith, Aranelle, Dasetta, Necon, Fyavolv, Mimvey, Nortrel 28, Zenchent, Lopreeza, Balziva, Xelria, OSHIH, Emzahh, Loestrin 21, Activella, Norethindrone, Junel, Camila, Taytulla, Cyonanz, Blisovi 24, Loestrin, Feirza, Tarina 24, Briellyn, Tri-Legest, Melodetta 24, Jinteli, Aurovela 24, Wera, Galbriela, Microgestin, Myfembree, Nortrel, Blisovi, ERRIN, Alyacen, Finzala, Meleya, Kaitlib, Nortrel 21, Orquidea, Rhuzdah, Nexesta, Incassia, XARAH, Jencycla, Hailey
Norethindrone Acetate
Brand Names
24FE, Nylia, Sharobel, Hailey 24, Tarina, Vyfemla, Deblitane, Wymzya, Aurovela, Lyleq, Mibelas 24, Etyqa, Luizza, Gallifrey, Junel 21, Microgestin 24, Affodel, Abigale, Femlyv, Philith, Aranelle, Dasetta, Necon, Fyavolv, Mimvey, Nortrel 28, Zenchent, Lopreeza, Balziva, Xelria, OSHIH, Emzahh, Loestrin 21, Activella, Norethindrone, Junel, Camila, Taytulla, Cyonanz, Blisovi 24, Loestrin, Feirza, Tarina 24, Briellyn, Tri-Legest, Melodetta 24, Jinteli, Aurovela 24, Wera, Galbriela, Microgestin, Myfembree, Nortrel, Blisovi, ERRIN, Alyacen, Finzala, Meleya, Kaitlib, Nortrel 21, Orquidea, Rhuzdah, Nexesta, Incassia, XARAH, Jencycla, Hailey
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: May 25, 2001
Classification: Progestin
Aurovela.
Osphena
Generic Name
Ospemifene
Osphena
Generic Name
Ospemifene
Form: Tablet
Method of administration: Oral
FDA approval date: April 01, 2023
Classification: Estrogen Agonist/Antagonist
OSPHENA is indicated for: OSPHENA is an estrogen agonist/antagonist indicated for: The treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
Paroxetine
Brand Names
Paxil, Brisdelle
Paroxetine
Brand Names
Paxil, Brisdelle
Form: Tablet, Suspension, Capsule
Method of administration: Oral
FDA approval date: July 30, 2003
Classification: Serotonin Reuptake Inhibitor
Paroxetine Capsules are indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Limitation of Use: Paroxetine capsules are not indicated for the treatment of any psychiatric condition. Paroxetine capsules contain a lower dose of paroxetine than that used to treat depression, obsessive compulsive disorder, panic disorder, generalized anxiety disorder, social anxiety disorder, and post-traumatic stress disorder. The safety and efficacy of this lower dose of paroxetine in paroxetine capsules have not been established for any psychiatric condition. Patients who require paroxetine for treatment of a psychiatric condition should discontinue paroxetine capsules and initiate a paroxetine-containing medication that is indicated for such use. Paroxetine capsules are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause (VMS) ( 1 ) Limitation of Use: Paroxetine capsules are not indicated for the treatment of any psychiatric condition ( 1 )
MethylTESTOSTERone
Brand Names
Estratest, Methitest
MethylTESTOSTERone
Brand Names
Estratest, Methitest
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: October 17, 1974
Classification: Androgen
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE FULL STRENGTH and ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH are indicated in the treatment of: Moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone. (There is no evidence that estrogens are effective for nervous symptoms or depression without associated vasomotor symptoms, and they should not be used to treat such conditions.) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE FULL STRENGTH and ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH HAVE NOT BEEN SHOWN TO BE EFFECTIVE FOR ANY PURPOSE DURING PREGNANCY AND ITS USE MAY CAUSE SEVERE HARM TO THE FETUS (SEE BOXED WARNING ).
Showing 1-5 of 10
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances